HighPoint Advisor Group LLC Purchases 769,163 Shares of Neonc Technologies Holdings, Inc. $NTHI

HighPoint Advisor Group LLC increased its holdings in shares of Neonc Technologies Holdings, Inc. (NASDAQ:NTHI) by 424.8% in the third quarter, according to its most recent disclosure with the SEC. The firm owned 950,232 shares of the company’s stock after purchasing an additional 769,163 shares during the period. HighPoint Advisor Group LLC’s holdings in Neonc Technologies were worth $8,628,000 as of its most recent filing with the SEC.

A number of other institutional investors have also recently bought and sold shares of the business. Bank of America Corp DE acquired a new stake in shares of Neonc Technologies in the second quarter valued at approximately $801,000. Global Retirement Partners LLC bought a new stake in Neonc Technologies in the 3rd quarter valued at $434,000. Royal Bank of Canada acquired a new stake in Neonc Technologies during the 1st quarter valued at $247,000. Foundations Investment Advisors LLC bought a new position in Neonc Technologies during the third quarter worth $100,000. Finally, SLT Holdings LLC bought a new position in Neonc Technologies during the third quarter worth $100,000.

Insider Buying and Selling

In other news, President Amir F. Heshmatpour bought 24,000 shares of the company’s stock in a transaction dated Friday, November 21st. The stock was bought at an average cost of $6.07 per share, for a total transaction of $145,680.00. Following the transaction, the president owned 2,986,000 shares of the company’s stock, valued at $18,125,020. This represents a 0.81% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Over the last 90 days, insiders have bought 31,100 shares of company stock valued at $192,099.

Analyst Upgrades and Downgrades

Several equities analysts have recently weighed in on NTHI shares. Weiss Ratings reissued a “sell (e+)” rating on shares of Neonc Technologies in a research report on Monday, December 29th. Zacks Research upgraded shares of Neonc Technologies to a “hold” rating in a research note on Wednesday, January 14th. One research analyst has rated the stock with a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat, Neonc Technologies presently has a consensus rating of “Reduce”.

Neonc Technologies Price Performance

NASDAQ NTHI opened at $9.71 on Thursday. Neonc Technologies Holdings, Inc. has a 12-month low of $3.20 and a 12-month high of $25.00. The firm has a 50-day moving average price of $8.88 and a two-hundred day moving average price of $8.51.

Neonc Technologies (NASDAQ:NTHI) last issued its quarterly earnings results on Friday, November 14th. The company reported ($0.45) earnings per share (EPS) for the quarter.

Neonc Technologies Profile

Neonc Technologies Holdings, Inc develops novel molecular technology that provides enhanced targeted delivery of technologies for treating central nervous system diseases. Its lead products in development include NEO100, which is in Phase 2a clinical trials for treating glioblastoma; and NEO212, a covalently conjugated molecule combining the chemotherapeutic drug temozolomide with perillyl alcohol that is completed preclinical testing. The company was incorporated in 2023 and is based in Los Angeles, California.